Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEBIRITUX: Irinotecan Drug-eluting Beads With Cetuximab vs Systemic Cetuximab and Irinotecan in Refractory Metastatic Colorectal Cancer
NCT01060423Phase 2Terminated
- Sponsor
- Hans-Joachim Schmoll
- Start
- Feb 2010
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irinotecan in colorectal cancer (CRC), sponsored by Hans-Joachim Schmoll. Started Feb 2010; status: terminated.
02
Drugs
irinotecan
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01060423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01060423.